Skip to content

the survey of pain injection of propofol

Different premedication admixture with propofol to attenuate pain severity induced by propofol injection: a double blind randomized clinical trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2012072310340N1
Enrollment
257
Registered
2012-07-28
Start date
2010-03-15
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain severity induced by propofol injection.

Interventions

Intervention 1: In second group (50 patients), 2 cc of Lidocaine 1% before use of Propofol was injected. Intervention 2: The third group (48 patients), received 2 ml of normal saline 0.09% before the
Treatment - Drugs
In second group (50 patients), 2 cc of Lidocaine 1% before use of Propofol was injected
The third group (48 patients), received 2 ml of normal saline 0.09% before the injection of Propofol
Group IV (54 patients) 50 mg Sodium Thiopental before injection of Propofol type Fresenius was injected
Group V (55 patients) also recieved 100µg Fentanyl before injection of Propofol
In first group (53 patients) 2mg/kg of Propofol type Fresenius One percent (MCT/LCT) was injected

Sponsors

Vice chancellor for research, Golestan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 55 Years

Inclusion criteria

Inclusion criteria: inclusion criteria: patient fully satisfied to be studied,between 15-55years-old and ASA1,2 exclusion criteria:A history of drug abuse, alcohol or taking any pain medication during 24 hours before surgery, a history of neurological disease, chronic pain syndrome, thrombofelebit, advanced systemic disease (such as advanced diabetes), and any contraindication based on injection of Propofol lead to patient withdrawal from the study

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: 24 houre after end of surgery. Method of measurement: Visual analog scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKazem Kazem Nejad

Golestan University of Medical Sciences

kazemnejad1341@yahoo.com+98 911 277 3711

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026